Featured Articles

  1. Research And Industry Join Forces As Modalities Merge

    How is current research driving the convergence of therapeutic modalities, and what implications does this have for patients and healthcare? Read on to find answers to these questions and more.

  2. Building A Broad Oncology Portfolio With SOTIO CEO Dr. Radek Špíšek

    Establishing an organization that can manage a diverse development pipeline for oncology therapies requires an equally diverse wealth of expertise.